Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8153617B2 · kind B2 · utility
7Cited by
93References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 11, 2008 |
| Grant date | Apr 10, 2012 |
| Priority date | — |
| Expiry date | Feb 28, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be applied to an oral surface of a human such that an oral malady may be inhibited and/or ameliorated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.